Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease
- 1 April 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 59 (4), 1466-1472
- https://doi.org/10.1046/j.1523-1755.2001.0590041466.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Plasma from ESRD patients inhibits nitric oxide synthase activity in cultured human and bovine endothelial cellsActa Physiologica Scandinavica, 2000
- Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the ratBritish Journal of Pharmacology, 1998
- Carvedilol and its Metabolites Suppress Endothelin-1 Production in Human Endothelial Cell CultureBlood Pressure, 1997
- Effect of Salt Intake and Inhibitor Dose on Arterial Hypertension and Renal Injury Induced by Chronic Nitric Oxide BlockadeHypertension, 1996
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Hypertension in mice lacking the gene for endothelial nitric oxide synthaseNature, 1995
- Advanced Glycosylation Endproducts in Diabetic Renal Disease: Clinical Measurement, Pathophysiological Significance, and Prospects for Pharmacological InhibitionBlood Purification, 1995
- Regulation of endothelial permeability by β-adrenoceptor agonists: Contribution of
adrenoceptors Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993 - Ethanol enhances the endothelial nitric oxide synthase response to agonists.Hypertension, 1993
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992